BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2023 9:52:18 AM | Browse: 404 | Download: 1595
 |
Received |
|
2023-02-01 06:35 |
|
Peer-Review Started |
|
2023-02-01 06:38 |
|
First Decision by Editorial Office Director |
|
2023-02-12 17:08 |
|
Return for Revision |
|
2023-02-12 17:08 |
|
Revised |
|
2023-02-25 04:54 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-05-04 03:13 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-05-04 22:47 |
|
Articles in Press |
|
2023-05-04 22:47 |
|
Edit the Manuscript by Language Editor |
|
2023-05-02 19:20 |
|
Typeset the Manuscript |
|
2023-06-07 01:46 |
|
Publish the Manuscript Online |
|
2023-06-16 09:52 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhong-Yang Jiang, Xi-Mei Ma, Xiao-Hui Luan, Zhen-Yu Liuyang, Yi-Yang Hong, Yuan Dai, Qing-Hua Dong and Guan-Yu Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81472213 |
| The Health Commission of Zhejiang Province |
2019ZD010 |
| The Health Commission of Zhejiang Province |
2019ZD029 |
| The Science Technology Department of Zhejiang Province |
LGF20H220001 |
| The Zhejiang Provincial Administration of Traditional Chinese Medicine |
2021ZA088 |
|
| Corresponding Author |
Guan-Yu Wang, MD, PhD, Surgeon, Department of Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou 310016, Zhejiang Province, China. wangguanyu@zju.edu.cn |
| Key Words |
BMI-1; Hepatic stellate cells; Colorectal cancer; Liver metastasis; Epithelial-mesenchymal transition |
| Core Tip |
This study revealed that BMI-1 was upregulated in liver cells during colorectal cancer (CRC) liver metastasis. BMI-1-activated LX2 hepatic stellate cells (HSCs) promoted CRC cell proliferation, migration, and the epithelial-mesenchymal transition both in vitro and in vivo. Mechanistically, transforming growth factor beta 1 was increased in BMI-1 overexpressed LX2 HSCs, and triggered the phosphorylation of downstream SMAD2/3 in CRC cells and the interaction of activated HSCs and CRC cells, thereby further promoting CRC progression. |
| Publish Date |
2023-06-16 09:52 |
| Citation |
Jiang ZY, Ma XM, Luan XH, Liuyang ZY, Hong YY, Dai Y, Dong QH, Wang GY. BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells. World J Gastroenterol 2023; 29(23): 3606-3621 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i23/3606.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i23.3606 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
